Typical milestones during the first six months of a physician-supervised GLP-1 program
Gallbladder issues : Including gallstones
doi: 10.3389/fimmu.2026.1897106 Received 01 June 2026 Revised 14 July 2026 Accepted 17 July 2026 Published 31 July 2026 Volume 17 - 2026 Edited by Abdullah Saeed, City of Hope National Medical Center, United States Reviewed by Longlong Tian, Lanzhou University, China Bao-Toan Dang, University of Connecticut, United States Updates Copyright 2026 Huang, Yu, Shi and Deng
Semaglutide- and tirzepatide-class medications carry real, documented risks discussed in the safety section above
Iucci.Importantly, GLP-1 medications do not directly cause heart palpitations or increase heart rate the way stimulant-based weight loss drugs can